compound was purified by column chromatography with ethyl acetate / dichloromethane (6:4) as eluent, leading to 484 mg (0.83 mmol, 83%) of compound 1. Deprotection was performed by dropwise addition of 6 mL of 4 M solution of hydrochloride in ethyl acetate to a solution of compound 1 (484 mg, 0.83 mmol) in ethyl acetate (10 mL). The reaction mixture was stirred at room temperature for 60 min. The resulting mixture was evaporated under vacuum and the residue was dissolved in 20 mL of ethyl acetate. The solution was again evaporated and the residue was triturated with anhydrous ether, leading to 422 mg (97%) of spacer arm 2 ( Figure 2 ).
Addition of Estradiol acidic derivative.
Estradiol acidic derivative was synthesized as described previously. 1 indicating its complete reduction. The reaction mixture was diluted with water (5 mL), acidified to pH 2 using 4M HCl, and then re-adjusted to pH 8 with Na 2 CO 3 . The mixture was extracted with ethyl acetate (2x20 mL). The organic phase was washed with brine, dried over anhydrous sulphate and evaporated to dryness, affording 17 mg (81%) of H 2 L E2 Salan. • Electrochemical immunosensor protocol.
Preparation of the oxovanadium complexes
Electrochemical measurements were performed using an Autolab PGSTAT100 were performed between each step using 100 µL of PBS (1X). Assays were performed in duplicate.
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